authors

• Mader, Gregory
• Mladsi, Deirdre
• Sanon, Myrlene
• Purser, Molly
• Barnett, Christine L
• Oberdhan, Dorothee
• Watnick, Terry
• Stephen L. Seliger, MD MS

publication date

• January 1, 2022

published in

• BMC nephrology  Journal

has subject area

• Antidiuretic Hormone Receptor Antagonists
• Clinical Trials, Phase III as Topic
• Disease Progression
• Humans
• Kidney Failure, Chronic
• Polycystic Kidney, Autosomal Dominant
• Time Factors
• Tolvaptan

Keywords

• Autosomal dominant polycystic kidney disease
• Disease modeling
• End-stage renal disease
• Renal function decline
• Tolvaptan

Digital Object Identifier (DOI)

• https://doi.org/10.1186/s12882-022-02956-8

PubMed ID

• 36258169

start page

end page

volume

• 23

issue

• 1